APA-viite

Bos, R., Rutten, L., van der Lubbe, J. E. M., Bakkers, M. J. G., Hardenberg, G., Wegmann, F., . . . Schuitemaker, H. (2020). Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses. NPJ Vaccines.

Chicago-tyylinen lähdeviittaus

Bos, Rinke, et al. "Ad26 Vector-based COVID-19 Vaccine Encoding a Prefusion-stabilized SARS-CoV-2 Spike Immunogen Induces Potent Humoral and Cellular Immune Responses." NPJ Vaccines 2020.

MLA-viite

Bos, Rinke, et al. "Ad26 Vector-based COVID-19 Vaccine Encoding a Prefusion-stabilized SARS-CoV-2 Spike Immunogen Induces Potent Humoral and Cellular Immune Responses." NPJ Vaccines 2020.

Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.